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Abstract To study the association between country of birth
and incident atrial fibrillation (AF) in several immigrant
groups in Sweden. The study population included all adults
(n = 3,226,752) aged 45 years and older in Sweden. AFwas
defined as having at least one registered diagnosis of AF in
the National Patient Register. The incidence of AF in dif-
ferent immigrant groups, using Swedish-born as referents,
was assessed by Cox regression, expressed in hazard ratios
(HRs) and 95% confidence intervals (CI). All models were
stratified by sex and adjusted for age, geographical residence
in Sweden, educational level, marital status, and neigh-
bourhood socioeconomic status. Compared to their Swed-
ish-born counterparts, higher incidence of AF [HR (95%
CI)] was observed amongmen fromBosnia 1.74 (1.56–1.94)
and Latvia 1.29 (1.09–1.54), and among women from Iraq
1.96 (1.67–2.31), Bosnia 1.88 (1.61–1.94), Finland 1.14
(1.11–1.17), Estonia 1.14 (1.05–1.24) and Germany 1.08
(1.03–1.14). Lower incidence of AF was noted among men
(HRs B 0.60) from Iceland, Southern Europe (especially
Greece, Italy and Spain), Latin America (especially Chile),
Africa, Asia (including Iraq, Turkey, Lebanon and Iran), and
among women from Nordic countries (except Finland),
Southern Europe, Western Europe (except Germany),
Africa, North America, Latin America, Iran, Lebanon and
other Asian countries (except Turkey and Iraq). In conclu-
sion, we observed substantial differences in incidence of AF
between immigrant groups and the Swedish-born popula-
tion. A greater awareness of the increased risk of AF
development in some immigrant groups may enable for a
timely diagnosis, treatment and prevention of its debilitating
complications, such as stroke.
Keywords Atrial fibrillation  Gender  First generation
immigrants  Neighbourhood  Second generation
immigrants  Socioeconomic status
Introduction
Atrial fibrillation (AF) is the most common form of
arrhythmia. AF is associated with significant morbidity, in
particular with an increased risk of stroke [1, 2]. In 2010,
the age-adjusted prevalence of AF worldwide was esti-
mated at approximately 0.6% among men and 0.4% among
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women [3]. The AF prevalence in Europe was previously
estimated to be around 1% [4]. One study conducted in
Sweden found the prevalence of a registered diagnosis of
AF to be around 2% [5]. As regards to people 20 years of
age and older, recent figures show a prevalence of AF in
Europe of 2% [6], and in Sweden of 3% [7].
Migration worldwide is on the increase. In Sweden, it is
estimated that approximately 17% of the registered
Swedish population is foreign-born (data from Statistics
Sweden) [8]. The health of immigrants upon arrival to their
new country often tends to be better than that of the native
population; something that has been termed as the ‘‘healthy
migrant effect’’. This improved health status in some
countries could be a result of a selective immigration
process in which people are granted entry to a new country
if they have passed a medical screening examination.
However, such a selection is uncommon for immigrants to
Sweden. Additionally, the health of immigrants tends to
decline with years spent living in their new adopted
country [9, 10]. The relation between immigration and
health is complex due to the ethnic, cultural and economic
diversity of immigrants. Ethnic differences in the incidence
and prevalence of AF [11], as well as in symptoms and
treatment [12], have been reported previously. In the
United States, a lower AF risk has earlier been reported
among Afro-Americans compared to individuals of white
European descent [13] and among Chinese and Hispanics
compared to non-Hispanic whites [11]. In Europe, AF rates
in the UK are lower among South Asians, despite a higher
cardiovascular risk profile, than in the native British pop-
ulation [14]. However, there are few other studies on this
topic besides those mentioned above.
Therefore, the aim of this study was to explore the risk
of being diagnosed with AF among first and second-gen-
eration immigrants in Sweden and whether that risk dif-
fered from the Swedish-born population, after taking
potential confounders into account.
Methods
Design
The registers used in the present study were the Total
Population Register and the National Patient Register.
Sweden’s nationwide population and health care registers
have exceptionally high completeness and validity [15].
Less than 1% of the data were missing when linking
clinical to national demographic and socioeconomic data.
Individuals were tracked using the personal identification
numbers, which are assigned to each resident of Sweden.
Migrants with a residence permit get a Swedish personal
identification number. Asylum seekers are thus not
included until they receive their residence permit, but in
general they form a limited number of individuals. These
identification numbers were replaced with serial numbers
to ensure anonymity. Subjects aged 45 years of age and
older were included in the study. The follow-up period ran
from January 1, 1998 until hospitalisation/out-patient
treatment of AF at age of diagnosis of 45 years or more,
death, emigration or the end of the study period on
December 31, 2012, whichever came first. Out-patient
diagnoses were included nationwide from 2001 and
onwards from specialist care, not primary health care.
Study population and co-morbidities
The study included the whole Swedish population aged
45 years and older. Patients with an AF diagnosis prior to
January 1, 1998 were excluded in order to ‘‘wash-out’’
those with pre-existing disease. Country of birth was reg-
istered and the present study was based on analyses of ten
regions (Nordic countries, Southern Europe, Western
Europe, Eastern Europe, Baltic countries, Central Europe,
Africa, North America, Latin America and Asia) and sep-
arate analyses from 27 countries (Supplementary Table 1).
Countries with less than 10 observed cases of AF were not
analysed separately. First-generation immigrants
(n = 434,440) were defined as those born outside Sweden
and were compared to Swedish-born individuals. ‘‘The date
of immigration’’ is actually the date of residence permit,
i.e. when the migrants get their Swedish personal identifi-
cation number. Second-generation immigrants were
defined (n = 121,414) as individuals born in Sweden with
at least one foreign-born parent and were compared to
individuals born in Sweden with two Swedish-born parents.
Patients with diagnosed AF were identified by the pres-
ence of the ICD-10 code (10th version of the World Health
Organization’s International Classification of Diseases) for
AF (I48) in the National Patient Register. AF diagnosed
before 1998, i.e. during the years 1987–1997 (according to
ICD-9 1987–1996 and ICD-10 1997) were excluded. We
also identified co-morbidities according to ICD-10 for the
following diagnoses: hypertension I10-I19, chronic rheu-
matic heart disease I05-I09, CHD I20-I25, heart failure I50,
stroke I60-I69, diabetes E10-E14, obesity E65-E68, alco-
holism and related disorders F10 and K70, and chronic
obstructive pulmonary disease (COPD) J40-J47.
Outcome variable
Time was calculated from January 1, 1998 until hospital-
isation/out-patient treatment of AF (among individuals at
an age of diagnosis of 45 years or older), death, emigration
or the end of the study period on December 31, 2012,
whichever came first.
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Demographic and socioeconomic variables
The study population was stratified by sex.
Age was used as a continuous variable in the analysis.
Educational attainment was categorised as B9 years
(partial or complete compulsory schooling), 10–12 years
(partial or complete secondary schooling) and[12 years
(attendance at college and/or university).
Geographic region of residence was included in order to
adjust for possible regional differences in hospital admis-
sions and was categorised as [1] large cities, [2] southern
Sweden and [3] northern Sweden. Large cities were defined
as municipalities with a population of [200,000 and
comprised the three largest cities in Sweden: Stockholm,
Gothenburg and Malmo¨.
Neighbourhood socioeconomic status
Neighbourhoods were derived from Small Area Market
Statistics (SAMS). These were originally created for com-
mercial purposes and pertain to small geographic areas with
boundaries defined by homogenous types of buildings. The
average population in each SAMS neighbourhood is
approximately 2000 people for Stockholm and 1000 people
for the rest of Sweden. A summary index was calculated to
characterise neighbourhood-level deprivation. The neigh-
bourhood index was based on information about female and
male residents aged 20–64 years. The logic for this is
because this age group represents those who are among the
most socioeconomically active in the population (i.e. a group
that has a stronger impact on the socioeconomic structure in
the neighbourhood compared to children, younger women
andmen, and retirees). The indexwas based on the following
four variables: low educational status (\10 years of formal
education); income from all sources, including interest and
dividends, that is\50% of the median individual income);
unemployment (excluding full-time students, those com-
pleting military service and early retirees); and receipt of
social welfare. The index was categorised into three groups:
more than one standard deviation (SD) below themean (high
SES or low-deprivation level), more than one SD above the
mean (low SES or high-deprivation level), and within one
SD of the mean (middle SES or middle-deprivation level)
[16], with neighbourhood status classified as high, middle or
low SES, corresponding to the categories low, middle and
high-deprivation in the index [17].
Statistical analysis
The number of AF cases was presented for first- and sec-
ond-generation immigrants and across baseline subject
characteristics. Cox regression analysis was used for esti-
mating the risk of incident AF in different immigrant
groups compared to the Swedish-born population. All
analyses were stratified by sex. Three models were used in
our analyses: Model 1 was adjusted for age and region of
residence in Sweden; Model 2 was adjusted for age, region
of residence in Sweden, educational level, marital status
and neighbourhood SES; Model 3 was constructed as
Model 2 with inclusion of co-morbidities. In addition, Cox
regression sensitivity analyses were performed in which
first-generation immigrants moving to Sweden within the
last 5 years of follow-up were excluded.
The study was approved by the regional ethics boards at
Karolinska Institutet and Lund University.
Results
Table 1 features the characteristics of the included samples
for analysis for first- and second-generation immigrants
45 years of age and above. There were 9.4% of people
diagnosed with AF among first-generation immigrants;
5.7% for second-generation immigrants. AF was less com-
mon among immigrants in general compared to Swedish-
born individuals. AF was also less common among females,
individuals with a higher level of formal education, married
individuals, and people living in northern Sweden, while AF
was more common among individuals with co-morbidities,
especially cardiovascular co-morbidities.
Table 2a, b show the incidence of AF in first generation
male and female immigrants, respectively, compared to their
Swedish-born counterparts. In comparison to Swedish-born
men, the incidence of AF was higher among male immi-
grants with Bosnian origin, after adjustment for age, region
of residence in Sweden, educational level, marital status,
neighbourhood SES and co-morbidity. By contrast, com-
pared to Swedish-bornmen, the incidence ofAFwas lower in
men originating from most other regions and countries, but
especially low (HRs B 0.60) among immigrant men from
Iceland, from Southern Europe (especially Greece, Italy and
Spain), Latin America (especially Chile), Africa, Asia and
specifically Iraq, Turkey, Lebanon and Iran. Compared to
Swedish-born women, the incidence of AF was higher
among immigrant women from Bosnia and Iraq and there
was a borderline significant increase among women from
Finland and Estonia. A lower incidence of AF was observed
among immigrant women from most other regions and
countries and was especially low for women (HRs B 0.60)
from Iceland, Greece, Italy, Africa, and Latin America.
Table 3a, b show the incidence of AF in the second-
generation male and female immigrants, respectively,
compared to their Swedish-born counterparts. An increased
incidence of AF was found only in the fully adjusted model
among males from the Netherlands and not among any
female immigrant groups, after adjusting for age, region of
Atrial fibrillation in immigrant groups: a cohort study of all adults 45 years of age and…
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Table 1 Population and
number of incident cases of
atrial fibrillation (AF) diagnoses
in the Swedish population, used




First-generation analysis Second-generation analysis
Population AF diagnosis Population AF diagnosis
No % No. % No % No. %
Total population 3,226,752 304,487 1,890,853 107,213
Gender
Males 1,520,562 47.1 159,769 52.5 950,316 50.3 70,631 65.9
Females 1,706,190 52.9 144,718 47.5 940,537 49.7 36,582 34.1
Country of origina
Sweden 2,792,312 86.5 278,472 91.5 1,769,439 93.6 101,985 95.1
Other countries 434,440 13.5 26,015 8.5 121,414 6.4 5228 4.9
Birth year
–1909 73,467 2.3 4945 1.6
1910–1919 323,206 10.0 51,267 16.8
1920–1929 602,445 18.7 106,131 34.9
1930-39 722,107 22.4 79,921 26.2 441,357 23.3 45,472 42.4
1940–1949 1,088,739 33.7 52,610 17.3 1,034,701 54.7 51,589 48.1
1950– 416,788 12.9 9613 3.2 414,795 21.9 10,152 9.5
Educational level
B9 1,511,090 46.8 162,796 53.5 606,689 32.1 38,917 36.3
10–12 811,538 25.2 68,676 22.6 569,256 30.1 29,557 27.6
[12 904,124 28.0 73,015 24.0 714,908 37.8 38,739 36.1
Region of residence
Large cities 1,075,763 33.3 110,525 36.3 642,798 34.0 38,166 35.6
Southern Sweden 1,424,349 44.1 140,915 46.3 868,490 45.9 49,178 45.9
Northern Sweden 726,640 22.5 53,047 17.4 379,565 20.1 19,869 18.5
Marital status
Married 2,612,169 81.0 235,927 77.5 1,515,664 80.2 82,165 76.6
Unmarried 614,583 19.0 68,560 22.5 375,189 19.8 25,048 23.4
Neighbourhood deprivation
Low 485,193 15.0 43,082 14.1 337,143 17.8 18,330 17.1
Middle 1,622,097 50.3 164,111 53.9 971,071 51.4 56,101 52.3
High 359,648 11.1 36,422 12.0 194,895 10.3 11,617 10.8
Unknown 759,814 23.5 60,872 20.0 387,744 20.5 21,165 19.7
Hospital diagnosis of COPD
No 3,024,792 93.7 271,514 89.2 1,793,433 94.8 96,629 90.1
Yes 201,960 6.3 32,973 10.8 97,420 5.2 10,584 9.9
Hospital diagnosis of obesity
No 3,199,756 99.2 300,514 98.7 1,868,020 98.8 104,092 97.1
Yes 26,996 0.8 3973 1.3 22,833 1.2 3121 2.9
Hospital diagnosis of CHD
No 2,747,889 85.2 203,705 66.9 1,705,792 90.2 79,507 74.2
Yes 478,863 14.8 100,782 33.1 185,061 9.8 27,706 25.8
Hospital diagnosis of diabetes
No 2,942,192 91.2 259,615 85.3 1,746,278 92.4 90,514 84.4
Yes 284,560 8.8 44,872 14.7 144,575 7.6 16,699 15.6
Hospital diagnosis of alcoholism and related disorders
No 3,160,834 98.0 297,828 97.8 1,832,992 96.9 102,324 95.4
Yes 65,918 2.0 6659 2.2 57,861 3.1 4889 4.6
Hospital diagnosis of stroke
No 2,895,083 89.7 227,755 74.8 1,784,381 94.4 90,851 84.7
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residence, educational level, marital status, neighbourhood
SES and co-morbidity. Second-generation male immi-
grants from Italy and Latin America had a lower incidence
(with HRs B 0.60) of AF compared to their Swedish-born
counterparts. Among second-generation immigrant
women, compared to Swedish-born women, a lower inci-
dence of AF (with HRs B 0.60) was observed for those
women with origin from Southern Europe, especially from
Italy.
The results of the sensitivity analyses performed in first-
generation immigrants (Supplementary Table 2) confirmed
the results from Table 2a, b, and only small differences
were observed.
Discussion
This study explored the risk of being diagnosed with
incident AF among first and second-generation immigrant
men and women in Sweden compared to Swedish-born
men and women aged 45 years and older. Both higher and
lower estimates of AF were detected in the different
immigrant groups. Higher estimates were found among
first-generation immigrants for both men and women from
Bosnia and among women from Iraq, while no excess
incidence of AF was found among second-generation
immigrants. Furthermore, compared to Swedes, lower
incidence of AF was found in first-generation immigrants
for most other immigrant groups, while this was true only
for a few groups of the second-generation immigrant
groups, i.e. among men from Germany and Hungary, and
women from Italy and Central Europe.
AF prevalence differs around the world and some dif-
ferences are to be expected, in particular a lower AF
incidence among immigrants of non-European descent
from non-Western countries [18]. This could explain the
lower incidence among immigrants from certain regions,
such as Africa, Latin America and many Asian countries.
Furthermore, individuals living in Northern Europe tra-
ditionally have a higher risk of coronary heart disease
(CHD), especially compared to Southern Europe. As
myocardial infarction is a risk factor for AF [19], the
lower AF incidence among most immigrant groups could
reflect a higher AF incidence and prevalence in Sweden
[6].
There were some findings that could not be easily
interpreted. For instance, the AF incidence differed among
immigrants from different regions of Europe, with lower
incidence among immigrants from most European regions.
However, there were some important exceptions, in par-
ticular the increased incidence among men and women
from Bosnia. Risk factors for AF include older age, sex,
genetics, hypertension, heart disease (heart failure and
coronary artery disease), being overweight and obese,
higher amount of pericardial fat, sleep apnea, atrial
dilatation and stretch, chronic kidney disease, smoking,
high alcohol consumption, diabetes and thyroid dysfunc-
tion [20]. The risk pattern differs in different immigrant
groups and could contribute to, and possibly explain, dif-
ferences in AF incidence. We were able to adjust for some
co-morbidities, especially cardiovascular co-morbidity, but
not for other clinical factors. Some ethnic differences in the
risk factor pattern for AF have been shown, i.e. hyperten-
sion [21], diabetes [22], smoking [23] and obesity [22].
Even if hypertension is the most commonly established risk
factor for AF worldwide, other factors such as rheumatic
and valvular heart diseases seem to be more important for
AF in populations living in Latin America, India, the
Table 1 contiuned
First-generation analysis Second-generation analysis
Population AF diagnosis Population AF diagnosis
No % No. % No % No. %
Yes 331,669 10.3 76,732 25.2 106,472 5.6 16,362 15.3
Hospital diagnosis of hypertension
No 2,573,075 79.7 180,959 59.4 1,542,546 81.6 56,754 52.9
Yes 653,677 20.3 123,528 40.6 348,307 18.4 50,459 47.1
Hospital diagnosis of heart failure
No 2,939,005 91.1 194,225 63.8 1,826,817 96.6 82,429 76.9
Yes 287,747 8.9 110,262 36.2 64,036 3.4 24,784 23.1
Hospital diagnosis of chronic rheumatic heart disease
No 3,220,896 99.8 301,799 99.1 1,888,802 99.9 106,320 99.2
Yes 5856 0.2 2688 0.9 2051 0.1 893 0.8
a Immigrant status in second generation was based on parental birth country
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Table 2 Incidence of [hazard
ratio (HR) with 95% confidence
intervals (95% CI)] AF in
(a) first-generation male
immigrants compared to





Model 1 Model 2 Model 3
HR 95% CI HR 95% CI HR 95% CI
(a)
Sweden 1 1 1
Nordic countries 0.76 0.74 0.78 0.85 0.83 0.87 0.83 0.81 0.86
Denmark 0.68 0.64 0.72 0.70 0.66 0.74 0.71 0.67 0.75
Finland 0.78 0.76 0.81 0.91 0.88 0.94 0.87 0.85 0.90
Iceland 0.24 0.16 0.36 0.29 0.20 0.44 0.34 0.22 0.50
Norway 0.80 0.75 0.85 0.86 0.81 0.91 0.87 0.82 0.93
Southern Europe 0.37 0.34 0.40 0.44 0.40 0.48 0.48 0.44 0.52
France 0.53 0.41 0.67 0.62 0.49 0.79 0.66 0.52 0.84
Greece 0.28 0.24 0.33 0.35 0.30 0.41 0.40 0.34 0.46
Italy 0.44 0.38 0.51 0.52 0.45 0.60 0.53 0.46 0.61
Spain 0.36 0.28 0.45 0.44 0.34 0.55 0.48 0.38 0.61
Other Southern Europe 0.34 0.25 0.48 0.36 0.26 0.50 0.41 0.29 0.57
Western Europe 0.70 0.67 0.74 0.76 0.73 0.80 0.77 0.74 0.81
The Netherlands 0.63 0.52 0.77 0.69 0.57 0.83 0.72 0.59 0.87
UK and Ireland 0.46 0.39 0.53 0.54 0.47 0.63 0.61 0.52 0.71
Germany 0.77 0.72 0.82 0.81 0.76 0.86 0.80 0.76 0.85
Austria 0.77 0.68 0.88 0.84 0.74 0.95 0.83 0.73 0.94
Other Western Europe 0.59 0.47 0.75 0.69 0.54 0.87 0.72 0.57 0.91
Eastern Europe 0.75 0.71 0.79 0.78 0.74 0.83 0.78 0.74 0.83
Bosnia 1.28 1.12 1.46 1.80 1.58 2.06 1.48 1.30 1.69
Yugoslavia 0.68 0.64 0.73 0.70 0.65 0.75 0.71 0.66 0.76
Croatia 0.73 0.58 0.92 0.68 0.55 0.86 0.73 0.58 0.92
Romania 0.75 0.62 0.90 0.76 0.63 0.92 0.75 0.62 0.90
Bulgaria 0.60 0.42 0.86 0.65 0.45 0.93 0.70 0.49 1.00
Other Eastern Europe 0.71 0.50 1.01 0.64 0.45 0.91 0.67 0.47 0.96
Baltic countries 1.05 0.97 1.14 1.10 1.02 1.20 1.07 0.99 1.16
Estonia 1.03 0.94 1.12 1.08 0.99 1.18 1.05 0.96 1.15
Latvia 1.17 0.96 1.42 1.21 0.99 1.47 1.19 0.98 1.44
Central Europe 0.79 0.74 0.84 0.79 0.75 0.84 0.75 0.71 0.80
Poland 0.76 0.69 0.84 0.77 0.70 0.85 0.73 0.67 0.81
Other Central Europe 0.80 0.70 0.92 0.81 0.71 0.93 0.78 0.68 0.89
Hungary 0.81 0.73 0.89 0.80 0.73 0.88 0.76 0.69 0.84
Africa 0.41 0.36 0.48 0.48 0.42 0.56 0.51 0.43 0.59
North America 0.61 0.54 0.69 0.69 0.61 0.78 0.72 0.64 0.82
Latin America 0.29 0.25 0.34 0.34 0.29 0.39 0.38 0.32 0.45
Chile 0.26 0.21 0.32 0.30 0.24 0.37 0.33 0.27 0.42
South America 0.34 0.27 0.43 0.39 0.31 0.49 0.45 0.36 0.57
Asia 0.48 0.45 0.51 0.55 0.52 0.59 0.53 0.49 0.56
Turkey 0.47 0.41 0.54 0.56 0.49 0.65 0.53 0.46 0.61
Lebanon 0.41 0.30 0.55 0.48 0.36 0.65 0.43 0.32 0.58
Iran 0.39 0.33 0.45 0.41 0.35 0.48 0.41 0.35 0.48
Iraq 0.80 0.68 0.92 1.00 0.86 1.16 0.83 0.71 0.96
Other Asia countries 0.45 0.40 0.51 0.52 0.47 0.59 0.51 0.46 0.58
Russia 1.07 0.93 1.23 1.11 0.97 1.28 1.01 0.88 1.16
(b)
Sweden 1 1 1
Nordic countries 0.96 0.94 0.98 1.01 0.99 1.04 0.97 0.95 0.99
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Table 2 continued
Model 1 Model 2 Model 3
HR 95% CI HR 95% CI HR 95% CI
Denmark 0.78 0.73 0.83 0.79 0.74 0.84 0.81 0.75 0.86
Finland 1.02 0.99 1.05 1.10 1.07 1.13 1.03 1.00 1.06
Iceland 0.37 0.24 0.57 0.43 0.28 0.66 0.50 0.32 0.78
Norway 0.91 0.86 0.96 0.92 0.87 0.97 0.89 0.85 0.94
Southern Europe 0.42 0.37 0.48 0.48 0.43 0.54 0.55 0.49 0.62
France 0.62 0.46 0.82 0.72 0.54 0.96 0.79 0.59 1.06
Greece 0.30 0.24 0.38 0.35 0.28 0.44 0.42 0.33 0.53
Italy 0.38 0.30 0.48 0.44 0.35 0.56 0.49 0.39 0.62
Spain 0.61 0.46 0.82 0.70 0.52 0.94 0.77 0.58 1.03
Other Southern Europe 0.57 0.38 0.87 0.59 0.39 0.90 0.66 0.44 1.00
Western Europe 0.90 0.86 0.95 0.97 0.92 1.02 0.96 0.91 1.01
The Netherlands 0.72 0.56 0.93 0.80 0.62 1.03 0.85 0.66 1.10
UK and Ireland 0.48 0.39 0.59 0.55 0.45 0.68 0.61 0.50 0.76
Germany 0.98 0.93 1.04 1.04 0.98 1.10 1.01 0.95 1.06
Austria 0.96 0.82 1.12 1.03 0.88 1.20 1.01 0.87 1.18
Other Western Europe 0.62 0.46 0.85 0.72 0.53 0.98 0.75 0.55 1.03
Eastern Europe 0.96 0.89 1.03 0.98 0.91 1.05 0.97 0.90 1.04
Bosnia 1.54 1.27 1.87 2.03 1.67 2.46 1.67 1.38 2.03
Yugoslavia 0.90 0.82 0.98 0.89 0.82 0.98 0.90 0.82 0.99
Croatia 1.05 0.78 1.41 0.99 0.74 1.34 1.06 0.79 1.43
Romania 0.81 0.63 1.04 0.86 0.67 1.11 0.80 0.62 1.03
Bulgaria 0.83 0.51 1.33 0.95 0.59 1.52 0.95 0.59 1.53
Other Eastern Europe 1.09 0.63 1.87 0.98 0.57 1.69 0.98 0.57 1.69
Baltic countries 1.05 0.97 1.14 1.13 1.05 1.23 1.08 0.99 1.17
Estonia 1.07 0.98 1.16 1.15 1.05 1.25 1.10 1.00 1.20
Latvia 0.96 0.77 1.20 1.05 0.84 1.30 0.97 0.78 1.21
Central Europe 0.90 0.84 0.97 0.93 0.87 1.00 0.87 0.81 0.94
Poland 0.91 0.83 1.01 0.94 0.85 1.04 0.86 0.78 0.95
Other Central Europe 0.77 0.65 0.91 0.81 0.69 0.96 0.81 0.68 0.95
Hungary 0.98 0.87 1.11 1.01 0.90 1.15 0.93 0.82 1.05
Africa 0.47 0.33 0.68 0.54 0.38 0.78 0.55 0.38 0.80
North America 0.80 0.71 0.90 0.87 0.77 0.98 0.89 0.79 1.01
Latin America 0.41 0.33 0.50 0.45 0.37 0.55 0.48 0.39 0.59
Chile 0.42 0.32 0.55 0.46 0.35 0.61 0.48 0.37 0.64
South America 0.39 0.29 0.54 0.44 0.32 0.60 0.48 0.35 0.65
Asia 0.81 0.75 0.89 0.89 0.81 0.97 0.83 0.76 0.91
Turkey 0.92 0.79 1.08 1.00 0.86 1.17 0.89 0.77 1.04
Lebanon 0.69 0.45 1.06 0.75 0.49 1.14 0.61 0.40 0.94
Iran 0.72 0.57 0.91 0.76 0.60 0.96 0.76 0.60 0.95
Iraq 1.55 1.23 1.96 1.91 1.51 2.41 1.52 1.20 1.92
Other Asian countries 0.65 0.56 0.76 0.71 0.61 0.83 0.71 0.61 0.83
Russia 0.98 0.85 1.14 1.03 0.89 1.19 0.92 0.80 1.07
Model 1 was adjusted for age and region of residence in Sweden; Model 2 was adjusted for age, region of
residence in Sweden, educational level, marital status and neighbourhood SES; Model 3 was constructed as
Model 2 with inclusion of co-morbidities
Significant values HRs and 95% CIs marked by bold
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Table 3 Incidence of [hazard
ratio (HR) with 95% confidence




(N = 950,316), (b) second-
generation female immigrants
compared to Swedish-born
individuals (N = 940,537)
Model 1 Model 2 Model 3
HR 95% CI HR 95% CI HR 95% CI
(a)
Sweden 1 1 1
Nordic countries 0.97 0.93 1.02 0.98 0.94 1.02 0.96 0.91 1.00
Denmark 0.95 0.86 1.05 0.95 0.86 1.05 0.97 0.88 1.07
Finland 0.99 0.93 1.06 1.00 0.94 1.06 0.96 0.90 1.02
Norway 0.96 0.89 1.04 0.96 0.89 1.04 0.94 0.87 1.02
Southern Europe 0.78 0.60 1.02 0.80 0.61 1.04 0.82 0.63 1.07
Italy 0.73 0.50 1.06 0.74 0.51 1.08 0.76 0.52 1.11
Western Europe 0.90 0.82 0.99 0.90 0.82 0.99 0.90 0.82 0.99
The Netherlands 1.37 0.95 1.99 1.38 0.95 2.00 1.47 1.01 2.13
UK and Ireland 1.11 0.83 1.48 1.12 0.84 1.49 1.12 0.84 1.50
Germany 0.86 0.76 0.96 0.86 0.77 0.96 0.85 0.76 0.95
Austria 0.86 0.65 1.14 0.86 0.65 1.15 0.84 0.63 1.12
Other Western Europe 0.78 0.45 1.38 0.79 0.45 1.39 0.92 0.52 1.62
Eastern Europe 0.88 0.63 1.22 0.88 0.64 1.22 0.84 0.61 1.17
Yugoslavia 0.85 0.56 1.29 0.85 0.56 1.30 0.80 0.52 1.21
Romania 0.85 0.46 1.58 0.86 0.46 1.60 0.90 0.48 1.67
Baltic countries 0.97 0.87 1.09 0.98 0.87 1.10 0.99 0.89 1.11
Estonia 0.95 0.84 1.07 0.95 0.84 1.08 0.98 0.86 1.11
Latvia 1.14 0.87 1.51 1.15 0.87 1.52 1.10 0.84 1.45
Central Europe 0.79 0.66 0.94 0.79 0.66 0.94 0.75 0.63 0.89
Poland 0.86 0.68 1.09 0.86 0.68 1.09 0.83 0.65 1.04
Other Central Europe 1.03 0.75 1.40 1.03 0.75 1.40 0.98 0.72 1.33
Hungary 0.40 0.25 0.66 0.40 0.25 0.66 0.38 0.23 0.61
Africa 0.42 0.13 1.29 0.42 0.14 1.30 0.47 0.15 1.44
North America 0.93 0.83 1.05 0.94 0.83 1.06 0.96 0.85 1.09
Latin America 0.59 0.27 1.31 0.60 0.27 1.33 0.60 0.27 1.34
Asia 0.65 0.42 1.02 0.66 0.42 1.04 0.68 0.43 1.06
Other Asian countries 0.84 0.52 1.35 0.85 0.53 1.37 0.92 0.58 1.49
Russia 1.12 0.94 1.34 1.12 0.94 1.35 1.11 0.93 1.34
(b)
Sweden 1 1 1
Nordic countries 1.04 0.98 1.10 1.04 0.98 1.11 0.99 0.93 1.05
Denmark 0.98 0.85 1.13 0.97 0.84 1.13 0.99 0.86 1.15
Finland 1.12 1.02 1.22 1.12 1.03 1.22 1.03 0.94 1.12
Norway 0.96 0.86 1.07 0.96 0.86 1.07 0.93 0.84 1.04
Southern Europe 0.51 0.31 0.84 0.53 0.33 0.87 0.58 0.36 0.95
Italy 0.24 0.09 0.64 0.25 0.09 0.67 0.28 0.11 0.75
Western Europe 0.84 0.73 0.97 0.86 0.75 0.99 0.91 0.79 1.05
The Netherlands 0.87 0.43 1.74 0.89 0.44 1.77 1.01 0.51 2.02
UK and Ireland 0.88 0.54 1.41 0.90 0.56 1.45 0.97 0.60 1.56
Germany 0.82 0.70 0.97 0.84 0.71 0.99 0.88 0.74 1.04
Austria 0.90 0.61 1.34 0.92 0.62 1.37 0.99 0.67 1.46
Other Western Europe 0.96 0.46 2.02 1.01 0.48 2.12 1.14 0.55 2.40
Eastern Europe 0.56 0.29 1.07 0.56 0.29 1.07 0.54 0.28 1.05
Yugoslavia 0.39 0.15 1.03 0.38 0.14 1.01 0.39 0.15 1.05
Romania 0.87 0.33 2.31 0.90 0.34 2.39 0.79 0.30 2.10
Baltic countries 0.90 0.77 1.06 0.92 0.78 1.09 0.91 0.78 1.08
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Middle East and Africa [24]. On a global scale, hyperten-
sion is more prevalent in Central and Eastern Europe and
also in Sub-Saharan Africa and South Asia [25] but we
found no increased AF incidence among most Central or
Eastern European immigrants. In Europe, hypertension is
more common among immigrants from Sub-Saharan
Africa and South Asia but is less common among immi-
grants from Middle-eastern countries [26]. In Sweden,
hypertension has been found to be lower among immi-
grants of non-European origin [27], i.e. among immigrants
with lower AF risks than Swedish-born individuals and
higher among Finnish immigrants. In Bosnians, the risk of
cardiovascular disorder (including CHD) has been shown
to be increased in both women and men [28], which may
partly explain their increased AF incidence as many risk
factors are common for both conditions. In contrast to
hypertension, the diabetes prevalence has been shown to be
higher among immigrants of Middle Eastern origin, espe-
cially females, than immigrants from the Nordic countries
[29]. This could possibly be linked to the increased AF
incidence among Iraqi women. There are also contradictive
findings in the literature regarding the relation between
traditional cardiovascular risk factors and AF, e.g. a lower
rate of AF among South Asians in the UK despite an
adverse cardiovascular risk factor profile [14], and a higher
AF risk among non-Hispanic whites in the US compared to
non-Hispanic blacks, Chinese and Hispanics despite a
lower prevalence of hypertension [11].
Dietary factors could be of importance for the devel-
opment of AF [30]. For instance, the Mediterranean diet in
the South European countries is associated with a lower
risk of CHD [31] and intake of olive oil has also been
associated with a lower AF risk [32]. In addition, high
intake of fish with high levels of omega-3 fatty acids has
also been found to prevent AF in some studies [33]. This
association may possibly explain the lower AF incidence
among Icelandic immigrants, even if the total evidence for
this is inconclusive [34]. Otherwise, the lower AF inci-
dence among immigrants from Iceland and Southern Eur-
ope could be attributed to their diet, which is high in
marine food. Contradictory to this, incidence of AF on
Iceland has increased during recent years [35]. Some of the
other risk factors for AF, such as smoking [23] and high
alcohol intake [30], seemed to be of minor importance to
the AF incidence in the present study.
The healthy migrant effect, i.e. more healthy subjects
tend to migrate [36], could be one important factor
explaining the lower incidence of AF among first-genera-
tion immigrants, as more well-educated people migrate to
Sweden from both Western and non-Western countries.
However, in contrast to most Nordic neighbouring coun-
tries, immigrants from the Baltic countries, some Eastern
European countries, and to some extent also Finland, tend
to belong to the labour force group of immigrants. One
Finnish twin study found that the twin who migrated to
Sweden tended to have more cardiovascular risk factors
than the non-migrant twin [37].
A novel finding in our study is the higher AF incidence
in some groups with a high rate of war refugees to Sweden,
e.g. from Bosnia during the 1990s and from Iraq after the
turn of the millennium. Refugees may have experienced
many stressful events, both before and during the migra-
tion, and stress has been shown to be associated with AF
[38]. The concept of allostasis, i.e. the physiological
Table 3 continued
Model 1 Model 2 Model 3
HR 95% CI HR 95% CI HR 95% CI
Estonia 0.88 0.74 1.05 0.90 0.75 1.08 0.88 0.74 1.06
Latvia 1.03 0.69 1.54 1.06 0.71 1.58 1.12 0.75 1.67
Central Europe 0.71 0.54 0.93 0.72 0.55 0.94 0.68 0.52 0.90
Poland 0.83 0.58 1.19 0.83 0.58 1.19 0.79 0.55 1.12
Other Central Europe 0.42 0.21 0.83 0.42 0.21 0.84 0.41 0.20 0.82
Hungary 0.79 0.47 1.34 0.80 0.47 1.35 0.77 0.46 1.30
Africa 0.90 0.29 2.79 0.93 0.30 2.89 1.27 0.41 3.95
North America 0.84 0.70 1.00 0.84 0.71 1.00 0.87 0.73 1.04
Latin America 0.48 0.12 1.92 0.49 0.12 1.94 0.60 0.15 2.38
Asia 0.50 0.22 1.11 0.51 0.23 1.14 0.53 0.24 1.18
Other Asian countries 0.57 0.24 1.36 0.59 0.25 1.42 0.64 0.26 1.53
Russia 1.04 0.81 1.34 1.05 0.82 1.36 0.99 0.77 1.28
Model 1 was adjusted for age and region of residence in Sweden; Model 2 was adjusted for age, region of
residence in Sweden, educational level, marital status and neighbourhood SES; Model 3 was constructed as
Model 2 with inclusion of co-morbidities
Significant values HRs and 95% CIs marked by bold
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response to acute stress [39] and of allostatic load, i.e. the
accumulated side effects of life-course stress is thus of
relevance; allostatic load is connected with the develop-
ment of cardiovascular risk factors [40]. Thus, experienc-
ing stressful events could possibly partially explain the
higher AF incidence among male and female immigrants
from Bosnia and female immigrants from Iraq. Another
possibility is that refugees seek hospital care more fre-
quently and will thus be more often examined and diag-
nosed with AF.
In addition to the more commonly recognised individual
factors, socioeconomic factors are also of importance;
lower family income and lower educational status have
been shown to increase the risk of AF [41]. We also
adjusted for neighbourhood-level SES as many immi-
grants, especially from non-Western countries, live in low
SES neighbourhoods in urban areas. Living in low SES
neighbourhoods is associated with an increased morbidity
risk of AF-associated diagnoses [42], including cardio-
vascular health [16] and diabetes [43]. The mobility of
individuals between different neighbourhoods is rather
small [17].
The AF incidence pattern among second-generation
immigrants differed in most cases only marginally com-
pared to their Swedish-born counterparts with two Swed-
ish-born parents, possibly due to acculturation, i.e. second-
generation immigrants tend to adopt the lifestyle and health
patterns of the host population over time and have a ten-
dency to develop AF at the same rate.
A relevant question to ask is whether it is possible in the
present study to recognise the finding in earlier studies that
the health of immigrants tends to decline with years living
in the new country [9, 10]. However, considering the
diversity of the results in the different immigrant groups in
the present study, as well as the diversity of the countries of
origin of the immigrants, we judge that the results from
such an analysis would be difficult to interpret.
This study has certain limitations. We had no data
available on the type of atrial fibrillation (paroxysmal, per-
sistent, or permanent). AF diagnoses were taken from the
National Patient Register covering diagnoses from in-hos-
pital patients and specialist open care, as data from primary
care were not available to us. According to the data from
Stockholm County this would cover 68% of all AF patients
[5]. However, we consider a hospital diagnosis of AF to be of
higher validity than a primary care diagnosis. Given that our
focus was predominantly on cardiovascular co-morbidity
and whether the relationship between neighbourhood SES
and all-cause mortality is independent of cardiovascular
comorbidity, we did not include other potential diagnoses
associated with mortality such as presence of cancer or other
non-cardiovascular medical prescriptions. In addition, we
did not have access to multiple measures of individual SES.
However, we adjusted our analyses for level of formal
education, which is a commonly used proxy for individual
SES [44]. As we explored multiple immigrant groups, there
is a risk of mass significance due to multiple testing.We also
performed a sensitivity analysis excluding subjects that had
arrived in Sweden during the last five years. The statistical
power to detect significant results also differed between the
immigrant groups owing to varying sample sizes, and the
power was lower among women, especially second-gener-
ation women.
Despite the limitations, one of the key strengths of this
study is the linkage of clinical data (less than 1% missing
data) from individual patients to national demographic and
socioeconomic data. The clinical data were also highly
complete; less than 2% of the total number of diagnoses
were missing [45]. The comprehensive nature of our data
made it possible to analyse men and women from all types
of sociodemographic backgrounds.
In conclusion, we found an increased incidence of AF
among certain immigrant groups, especially among immi-
grants from some war-torn regions, and a lower incidence
among immigrant groups from countries with a tradition-
ally healthy diet. From a clinical point of view, it is
important to be aware of the increased incidence of AF in
some immigrant groups in order to enable for a timely
diagnosis, treatment and prevention of debilitating com-
plications associated with AF, such as ischaemic stroke.
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